FDA Recall Terminated Historical recordClass II
Moxifloxacin 1 mg/mL in Sterile Balanced Salt Solution (BSS) Intravitreal Injection, 1 mL Total Volume in a 2 mL Vial, Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-003-35
- Reason
- Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters
- Published
- October 19, 2016
- Distribution
- Nationwide
